BID Antibody

BH3 Interacting Domain Death Agonist , Mouse Anti Human
Cat. No.
BT13077
Source
Synonyms
BH3-interacting domain death agonist, p22 BID, BID, FP497, MGC15319, MGC42355.
Appearance
Purity
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Product Specs

Introduction
BID, with the accession number NP_001187, is a pro-apoptotic protein belonging to the Bcl-2 family, characterized by the presence of only the BH3 domain. Upon activation of apoptotic signaling pathways, BID interacts with Bax, another member of the Bcl-2 family known for its role in regulating cell death. This interaction leads to the formation of a heterodimer, facilitating the insertion of Bax into the outer mitochondrial membrane. Consequently, Bax triggers the opening of the mitochondrial voltage-dependent anion channel (VDAC), resulting in the release of cytochrome c and other pro-apoptotic factors from the mitochondria. This cascade of events ultimately activates caspases, leading to apoptosis. BID acts as a mediator of mitochondrial damage induced by caspase-8 (CASP8). CASP8 cleaves BID, and the COOH-terminal fragment translocates to the mitochondria, where it initiates cytochrome c release. Notably, the p15 BID, a major proteolytic product of BID, plays a crucial role in cytochrome c release. While Isoforms 1, 2, and 4 of BID induce ice-like proteases and apoptosis, Isoform 3 does not exhibit pro-apoptotic activity.
Formulation
1mg/ml in PBS, pH 7.4, with 0.1% Sodium Azide.
Storage Procedures
For storage up to 1 month, maintain the product at 4°C. For extended storage periods, store at -20°C. Avoid repeated freeze-thaw cycles.
Stability / Shelf Life
The product remains stable for 12 months when stored at -20°C and for 1 month at 4°C.
Applications
The BID antibody has undergone rigorous testing through ELISA and Western blot analysis to ensure its specificity and reactivity. However, considering the variability in applications, it is recommended to titrate the reagent for each specific experiment to achieve optimal results. For Western blot analysis, the recommended dilution range is 1:1,000 to 1:2,000, with a starting dilution of 1:1,000.
Synonyms
BH3-interacting domain death agonist, p22 BID, BID, FP497, MGC15319, MGC42355.
Purification Method
BID antibody was purified from mouse ascitic fluids by protein-G affinity chromatography.
Type
Mouse Anti Human Monoclonal.
Clone
P4D3AT.
Immunogen
Anti-human BID mAb is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human BID amino acids 1-195 purified from E. coli.
Ig Subclass
Mouse IgG1 heavy chain and κ light chain.

Product Science Overview

BH3 Interacting Domain Death Agonist (BID)

BH3 Interacting Domain Death Agonist (BID) is a pro-apoptotic member of the Bcl-2 protein family. The Bcl-2 family proteins are crucial regulators of apoptosis, a form of programmed cell death essential for maintaining cellular homeostasis and development . BID is unique among the Bcl-2 family members as it contains only the BH3 domain, which is critical for its pro-apoptotic function .

Structure and Function

BID is synthesized as an inactive precursor that, upon receiving apoptotic signals, is cleaved by caspase-8 into a truncated form known as tBID . This truncated form translocates to the mitochondria, where it interacts with other Bcl-2 family proteins such as Bax and Bak . This interaction leads to the permeabilization of the mitochondrial outer membrane, resulting in the release of cytochrome c and other pro-apoptotic factors . These events ultimately lead to the activation of caspases and the execution of apoptosis .

Role in Disease

BID plays a significant role in various physiological and pathological processes. Its expression is regulated by the tumor suppressor protein p53, linking it to p53-mediated apoptosis . Dysregulation of BID has been implicated in several diseases, including cancer, where its pro-apoptotic function may be compromised, leading to uncontrolled cell proliferation .

Mouse Anti-Human Antibodies

Mouse anti-human antibodies are secondary antibodies generated by immunizing mice with human antigens. These antibodies are widely used in research and diagnostic applications due to their specificity and ability to bind to human proteins .

Production and Applications

Mouse anti-human antibodies are produced by immunizing mice with human immunoglobulins or other human proteins. The immune response in mice generates antibodies that specifically recognize and bind to the human antigens . These antibodies are then harvested and purified for use in various applications, including:

  • Western Blotting: Detecting specific proteins in a sample.
  • ELISA (Enzyme-Linked Immunosorbent Assay): Quantifying the presence of specific antigens or antibodies.
  • Flow Cytometry: Analyzing the expression of cell surface and intracellular molecules.
  • Immunohistochemistry: Visualizing the distribution and localization of specific proteins in tissue sections .
Advantages and Considerations

Mouse anti-human antibodies offer several advantages, including high specificity and the ability to amplify signals, enhancing detection sensitivity . However, their use can sometimes lead to the development of Human Anti-Mouse Antibodies (HAMA) in patients, which can interfere with diagnostic tests and therapeutic applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.